1) Azuma T, Ishimaru H, Hatta K, Kori Y:Improved response to infliximab after leukocytapheresis in a patent with rheumatoid arthritis. Mod Rheumatol 2007;17:253-5 2) Eguchi K, Saito K, Kondo M, et al:LCAP Investigators in Kyushu College of Rheumatology(LIKCR). Enhanced effect of high-dose leukocytapheresis using a large filter in rheumatoid arthritis. Mod Rheumatol 2007;17:481-5 3) 日高利彦,橋場弥生,甲斐泰文,他:当院における関節リウマチに対する白血球除去療法の治療効果.臨床リウマチ2013;25:255-62 4) Hidaka T, Suzuki K, Matsuki Y, et al:Filtration leukocytapheresis therapy in rheumatoid arthritis:a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:431-7 5) Hidaka T, Suzuki K:Efficacy of filtration leukocytapheresis on rheumatoid arthritis with vasculitis. Ther Apher 1997;1:212-4 6) Itoh Y, Takeshita Y, Ozawa Y, et al:A case report of leukocytapheresis for refractory leg ulcers complicated with rheumatoid arthritis. Ther Apher Dial 2006;10:419-24 7) Izumi Y, Tominaga M, Iwanaga N, et al:Twenty-four-week follow-up examination of a leukocytapheresis therapy in rheumatoid arthritis. Mod Rheumatol 2006;16:20-3 8) Kempe K, Tsuda H, Yang K, et al:Filtration leukocytapheresis therapy in the treatment of rheumatoid arthritis patients resistant to or failed with methotrexate. Ther Apher Dial 2004;8:197-205 9) Kitagaichi M, Kusaoi M, Tsukahara T, et al:Safety and efficacy of the leukocytapheresis procedure in eighty-five patients with rheumatoid arthritis. Transfus Apher Sci 2016;55:225-32 10) Maeshima K, Torigoe M, Iwakura M, et al:Successful leukocytapheresis therapy in a patient with rheumatoid arthritis on maintenance hemodialysis. Mod Rheumatol 2015;25:154-7 11) 松木泰憲,高見澤光世,日高利彦,他:白血球除去療法が有効であった下腿潰瘍合併悪性関節リウマチの1例.リウマチ科1996;15:472-7 12) Ogawa H, Matsumoto Y:The efficacy of plasmapheresis or leukocytapheresis for articular and extraarticular manifestations of rheumatoid arthritis. Ther Apher 1997;1:330-5 13) 小沼心,山路健:関節リウマチに対する白血球除去療法(臨床成績を中心に).日アフェレシス会誌2009;28:44-9 14) Sakai Y, Sakai S, Otsuka T, et al:Efficacy of high-throughput leukocytapheresis for rheumatoid arthritis with a reduced response to infliximab. Ther Apher Dial 2009;13:179-85 15) Sawada J, Kimoto O, Suzuki D, et al:Investigation of the clinical usefullness of leukocytapheresis on rheumatoid arthritis resistant to or failed with the other treatments. Nihon Rinsho Meneki Gakkai Kaishi 2009;32:499-505(in Japanese) 16) 鈴木王洋,松木泰憲,佐川昭,他:悪性関節リウマチに対するリンパ球除去療法の有用性確認試験.日アフェレシス会誌1996;15:303-19 17) Ueki Y, Nakamura H, Kanamoto Y, et al:Comparison of lymphocyte depletion and clinical effectiveness on filtration leukocytapheresis in patients with rheumatoid arthritis. Ther Apher 2001;5:455-61 18) Ueki Y, Sagawa A, Tanimura K, et al:A multicenter study of leukocytapheresis in rheumatoid arthritis. Clin Exp Rheumatol 2007;25:810-6 19) Ueki Y, Yamasaki S, Kanamoto Y, et al:Evaluation of filtration leucocytapheresis for use in the treatment of patients with rheumatoid arthritis. Rheumatology(Oxford)2000;39:165-71 20) Yoshida S, Takeuchi T, Maeda Y, et al:Ultrasound evaluation of the effects of leukocytapheresis on rheumatoid arthritis. Ther Apher Dial 2014;18:509-14